跳至主要内容
临床试验/NCT07027891
NCT07027891招募中不适用

ROMIAE 2 Trial: Randomized Controlled Trial for Managing Suspicious Acute Myocardial Infarction in ED Using AI-ECG

CHA University12 个研究点 分布在 1 个国家目标入组 4,670 人开始时间: 2025年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
4,670
试验地点
12
主要终点
30 Days MACE(Major adverse cardiac events)

研究概览

简要总结

This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •chest pain
  • •suspicious of acute myocardial infarction

排除标准

  • •Revisit of same symptoms within 1 week
  • •traumatic chest pain
  • •Pneumothorax
  • •Transferred from other hospital diagnosed of AMI
  • •Cardiac arrest
  • •Chest pain of clearly non-cardiac etiology
  • •declined to participate in the study

研究组 & 干预措施

Control group

No Intervention

The patients in control group would be managed with usual care using HEART score in addition to recent acute coronary syndrome guideline.

AI-ECG group

Experimental

The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.

干预措施: AI-ECG (Device)

结局指标

主要结局

30 Days MACE(Major adverse cardiac events)

时间窗: 30 days

Death, acute myocardial infarction, stroke, target vessel revascularization, stent thrombosis within 30 days from index visit

次要结局

  • AI-ECG 30 days MACE prediction performance(30 Days)
  • AI-ECG acute myocardial infarction (index visit) discrimination performance(30 Days)
  • Medical resources utilization(30 days)
  • Medical resources utilization(24 hours)
  • Missed acute myocardial infarction at index visit(30 days)
  • AI-ECG 30 days MACE prediction performance(30 days)
  • AI-ECG acute myocardial infarction (index visit) discrimination performance(30 days)
  • Medical resources utilization(7 Days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyuseok Kim

Professor, MD, PhD

CHA University

研究点 (12)

Loading locations...

相似试验